Clinical trialNCT04575935RecruitingPhase 3Interventional

Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial

SponsorM.D. Anderson Cancer CenterEnrollment580Advanced Ovarian CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Serous NeoplasmFallopian Tube Transitional Cell CarcinomaOvarian Clear Cell Adenocarcinoma+19 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jose A Rauh-Hain
M.D. Anderson Cancer Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Arthur J.E. Child Comprehensive Cancer Centre - Calgary
Calgary, Canada
Gregg Nelson
Recruiting
University Health Network - Princess Margaret Cancer Centre
Toronto, Canada
Liat Hogen
Recruiting

Italy

Sant'Orsola Hospital Di Bologna
Bologna, Italy
Pierandrea De laco
Recruiting
Fondazione Policlinico Universitario Agostino Gemelli Irccs
Rome, Italy
Anna Fagotti
Recruiting

Mexico

Instituto Nacional de Cancerología (mexico)
Tlalpan, Mexico
David Isla Ortiz
Recruiting

Netherlands

Amsterdam Umc - Locatie Amc | H5zuid 154
Amsterdam, Netherlands
Luc van Lonkhuijzen
Recruiting

United States

University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
Abdulrahman Sinno, MD
Recruiting
Cleveland Clinic Foundation - Florida
Weston, Florida, United States
Joel Cardenas
Recruiting
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting
Massachusetts General Hospital
Boston, Massachusetts, United States
Alexander Melamed
Recruiting
Nyu Langone Health
Mineola, New York, United States
Edward Jimenez, MD
Recruiting
Columbia University Medical Center
New York, New York, United States
Jason D. Wright, MD
Recruiting
Duke
Durham, North Carolina, United States
Leah McNally, MD
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Chad Michener
Recruiting
St. Luke'S University Health Network
Bethlehem, Pennsylvania, United States
Nicholas Taylor, MD
Recruiting
Houston Methodist
Houston, Texas, United States
Pedro Ramirez
Recruiting
Lyndon Baines Johnson General
Houston, Texas, United States
Jose Rauh-Hain, MD
Recruiting
M D Anderson Cancer Center
Houston, Texas, United States
Jose A. Rauh-Hain
Recruiting
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Active, not recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 5 Aug 2020
Primary completion: 31 Dec 2028
Completion: 31 Dec 2028
Last update posted: 5 Mar 2026
Registered enrollment: 580
Registry id: NCT04575935

Cross-registrations

Other registry (CTRP (Clinical Trial Reporting ProgramNCI-2020-04165

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.